Skip to content

Public FDA record

Z-1729-2025: Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007

Recall record Z-1729-2025 for Remote Diagnostic Technologies Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1729-2025
Company in FDA record
Remote Diagnostic Technologies Ltd.
FDA classification date
May 7, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Patient Monitor software update to address issues:1)May freeze at startup with MPM Application error and Attention Restart Required messages,2)Monitor may freeze and reboot at start of 12-lead ECG or after, 3)May reboot after intermittent connection with Smart Mount, 4) 12-lead ECG measurements with Louvain algorithm and software before vx.36 could produce inaccurate rhythm/morphology statements.

Source facts

Action
On 4/15/2025, correction notices were mailed to customers and distributors informing them of the following: I) The User/Operator Manual provides precautions and warnings on maintaining appropriate power or battery supply, which may reduce the risk of occurrence of an "MPM Application" software error message: -Warning (In Chapter 2, Getting started): Ensure the latches on both sides of the battery are fully engaged prior to using the Tempus - an incorrectly fitted battery could result in the tempus losing power during use. -Note: Before removing the battery, you must switch off the Tempus Pro by pressing the power button. Do not remove the battery when the Tempus is on (unless there is a power supply attached to the device). II) If you have confirmed that your Tempus Pro has the standard (Louvain) algorithm, continue to follow the User/Operator Manual, which warns users to not make evaluations based solely on interpretation statements from the algorithm. -Warning (In Chapter 6, Taking medical readings): ECG interpretation performed by software is not a substitute for review and evaluation of ECG recordings by a qualified clinician. Keep a copy of this notice with your device until you receive the correction. Complete and return the response form via email to https://philips.efmfeedback.com/se/705E3ED80DE11FAF In addition, distributors were asked to do the following: - Modify the Response Form to substitute your firm's email and fax information. - Send a copy of this Urgent Medical Device Correction (with modified response form) to each customer to whom you distributed the affected product. Philips has developed a software update to resolve these issues that is expected to be available Q3 2025 via FCO86700012. If you need any further information or support concerning this issue, please contact the firm at (800) 722-9377 or email RDT.Recall.Response@Philips.com
Initiated
2025-04-15
Root cause
Software design
Distribution
Worldwide - US Nationwide distribution including in the states of AZ, VA, FL, CA, TX, NM, IA, NJ, TN, OH, KS, IN, NC, IL, WY, WI, NV, NY, NE, PA, AL, , MA, GA, MO, CO, OK, KY, OR, MS, MI, HI, WA, UT, WV, ID, ND, NH, MN, MT, ME, MD, DE, DC and the countries of AU, GB, IT, SA, DE, AE, BO, FR, ES, BE, IL, SG, CA, IE, TH, NL, MY, AT, DK, RO, CH, IS, PT, NO, HK, PL, KY, OM, CZ, SI, SL, ZA, AF, SE, FI.
Recall number
Z-1729-2025
Recall status
Open, Classified
CDRH record ID
213456
FDA classified
2025-05-07
Recall event number
96719

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗